Pharmagen Limited
Registered name: PHARMAGEN LIMITED
Part of Aurelius Crocodile Limited groupPharmagen Limited made £2.6m revenue and £68.5k profit in the year to 31 Mar 2025.
Pharmagen Limited’s revenue fell 2% to £2.6m in the year to 31 Mar 2025, with £68.5k profit. The company is classified under “dispensing chemist in specialised stores” and is based in Warwick; we hold 3 years of its filed accounts.
- Status
- Active
- Location
- Warwick
- Age
- 74 yrs · since 1952
- Type
- Private Limited Company
Key figures
Financial history
| Year to | 31 Mar 2023 | 31 Mar 2024 | 31 Mar 2025 |
|---|---|---|---|
| Disclosure | Full P&L | Full P&L | Full P&L |
| Profit & loss | |||
| Revenue (turnover) | £2.8m | £2.7m | £2.6m |
| Cost of sales | −£1.6m | −£2.4m | −£2.3m |
| Gross profit | £1.2m | £266k | £301k |
| Operating profit | £159k | £94.9k | £104k |
| Profit before tax | £58.1k | £94.9k | £104k |
| Profit after tax | £68.8k | £94.9k | £68.5k |
| Profit (best available) | £68.8k | £94.9k | £68.5k |
| Employees (average) | — | — | — |
| Ratios | |||
| Profit margin | 2.4% | 3.5% | 2.6% |
| Gross margin | 41.7% | 10% | 11.5% |
| Growth (year on year) | |||
| Revenue growth | — | ▼5.5% | ▼2.2% |
| Profit growth | — | ▲37.8% | ▼27.8% |
| Balance sheet — indirect signals, not revenue | |||
| Net assets | — | — | — |
| Source | Accounts · bulk data Nov 2024 | Accounts · bulk data Nov 2024 | Accounts · bulk data Dec 2025 |
How the business works
- Profit margin
- 2.6%
- Profit ÷ revenue.
- Gross margin
- 11.5%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- —
- Revenue ÷ average employees.
- Profit per employee
- —
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- —
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- —
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- —
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- —
- Now —
- Cash at bank
- —
- Now —
- Headcount
- —
- Now —
- Deferred income
- —
- Now —
- Fixed assets
- —
- Now —
Group structure
Ownership chain
- Aurelius Crocodile Limitedultimate parent75–100%
- Aurelius Fox Limited75–100%
- Aurelius Elephant Limited75–100%
- Admenta UK Limited75–100%
- Aah Pharmaceuticals Limited75–100%
- Pharmagen Limitedthis company
Bands show the share of ownership each company holds in the one below it.
Sister companies (3)
- Aah Builders Supplies LimitedFigures not disclosed
- Barclay Pharmaceuticals LimitedFigures not disclosed
- Sangers (Northern Ireland) LimitedFigures not disclosed
From the Persons with Significant Control register (corporate controllers only).
Sources
Latest figures from accounts for the year to 31 Mar 2025 (profit £68.5k), from the Companies House accounts bulk data published Dec 2025. Spotted an error? Request a correction.
Updated from Companies House on 16 Oct 2026
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.